Showing results (871-880 of 1,526) with videos related to

Sort By:
Pageof 153
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2016
Predicting Pathologic Response of Esophageal Cancer to Neoadjuvant Chemotherapy: The Implications of Metabolic Nodal Response for Personalized TherapyJohn M Findlay, Kevin M Bradley, Lai Mun Wang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2018
Lifetime exposure to ultraviolet radiation and the risk of multiple sclerosis in the US radiologic technologists cohort studyLisa G Gallagher, Sindana Ilango, Annette Wundes, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 20, 2023
Nanotube-Like Electronic States in [5,5]-C<sub>90</sub> Fullertube MoleculesÓscar Jover, Alberto Martín-Jiménez, Hannah M Franklin, et al.
BMJ Open|February 11, 2017
Can purchasing information be used to predict adherence to cardiovascular medications? An analysis of linked retail pharmacy and insurance claims dataAlexis A Krumme, Gabriel Sanfélix-Gimeno, Jessica M Franklin, et al.
Free Radical Biology & Medicine|September 29, 2015
Discovery of a novel neuroprotectant, BHDPC, that protects against MPP+/MPTP-induced neuronal death in multiple experimental modelsCheong-Meng Chong, Dan Ma, Chao Zhao, et al.
Prenatal Diagnosis|November 29, 2013
The impact of HIV infection and antiretroviral therapy on the predicted risk of Down syndromeThomas G Charlton, Jamie M Franklin, Melanie Douglas, et al.
American Journal of Epidemiology|December 6, 2018
Multinomial Extension of Propensity Score Trimming Methods: A Simulation StudyKazuki Yoshida, Daniel H Solomon, Sebastien Haneuse, et al.
Nature Biotechnology|December 6, 2016
MRI measurements of reporter-mediated increases in transmembrane water exchange enable detection of a gene reporterFranz Schilling, Susana Ros, De-En Hu, et al.
Bone Marrow Transplantation|December 14, 2011
Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapyP Ljungman, A Locasciulli, V G de Soria, et al.
Pharmacogenetics and Genomics|July 26, 2005
Dopamine transporter (SLC6A3) 5' region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's diseaseSamir N Kelada, Paola Costa-Mallen, Harvey Checkoway, et al.
Pageof 153